-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Reiterates Outperform on Amrize, Raises Price Target to $70

Benzinga·02/19/2026 16:10:18
Listen to the news
Oppenheimer analyst Bryan Blair reiterates Amrize (NYSE:AMRZ) with a Outperform and raises the price target from $64 to $70.